Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Copolov

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
The Australian and New Zealand Journal of Psychiatry|April 1, 1997
Ocular abnormalities in chronic schizophrenia: clinical implicationsD Smith, C Pantelis, J McGrath, et al.
Schizophrenia Research|December 14, 1999
Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophreniaE C Mallard, A Rehn, S Rees, et al.
Biological Psychiatry|November 5, 1997
The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophreniaP L Marzella, C Hill, N Keks, et al.
Clinical Endocrinology|November 1, 1983
Insulin hypoglycaemia and cholinergic blockade: response of plasma immunoreactive beta-endorphinD Copolov, J Jethwa, A Stern, et al.
The Pharmacogenomics Journal|August 22, 2003
Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrowA Pereira, A McLaren, W R Bell, et al.
Molecular Psychiatry|July 13, 2000
Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neuronsD Lee, W Huang, L Wang, et al.
Neurochemistry International|April 23, 1999
No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophreniaB Dean, E Tomaskovic-Crook, K Opeskin, et al.
Schizophrenia Research|June 27, 2000
Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophreniaD Pralong, E Tomaskovic-Crook, K Opeskin, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 10, 2000
Steady-state visually evoked potential topography during the continuous performance task in normal controls and schizophreniaR B Silberstein, P Line, A Pipingas, et al.
Molecular Medicine (Cambridge, Mass.)|December 16, 1998
No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampusL Naylor, B Dean, A Pereira, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
The Australian and New Zealand Journal of Psychiatry|April 1, 1997
Ocular abnormalities in chronic schizophrenia: clinical implicationsD Smith, C Pantelis, J McGrath, et al.
Schizophrenia Research|December 14, 1999
Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophreniaE C Mallard, A Rehn, S Rees, et al.
Biological Psychiatry|November 5, 1997
The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophreniaP L Marzella, C Hill, N Keks, et al.
Clinical Endocrinology|November 1, 1983
Insulin hypoglycaemia and cholinergic blockade: response of plasma immunoreactive beta-endorphinD Copolov, J Jethwa, A Stern, et al.
The Pharmacogenomics Journal|August 22, 2003
Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrowA Pereira, A McLaren, W R Bell, et al.
Molecular Psychiatry|July 13, 2000
Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neuronsD Lee, W Huang, L Wang, et al.
Neurochemistry International|April 23, 1999
No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophreniaB Dean, E Tomaskovic-Crook, K Opeskin, et al.
Schizophrenia Research|June 27, 2000
Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophreniaD Pralong, E Tomaskovic-Crook, K Opeskin, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 10, 2000
Steady-state visually evoked potential topography during the continuous performance task in normal controls and schizophreniaR B Silberstein, P Line, A Pipingas, et al.
Molecular Medicine (Cambridge, Mass.)|December 16, 1998
No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampusL Naylor, B Dean, A Pereira, et al.
Pageof 6